Misconceptions IV - The hypophosphatemia of primary hyperparathyroidism is the result of renal phosphate wasting

Bone

Volumn 35, Issue 2, 2004, Pages 345-347

  Parfitt, A Michael ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELECTROPHYSIOLOGY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE POTENTIAL; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; URINARY EXCRETION;

HUMANS; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY;

EID: 3242731381     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.03.032     Document Type: Article

References (16)

1. Biber J., Hernando N., Traebert M., Volkl H., Murer H. Parathyroid hormone-mediated regulation of renal phosphate reabsorption. Nephrol., Dial., Transplant. 15:2000;29-30
2. Bijvoet O.L.M. The importance of the kidneys in phosphate homeostasis. Avioli L., Bordier Ph., Fleisch H., Massy S.P., Slatopolsky E. Phosphate Metabolism Kidney and Bone. 1976;421-474 Armour Montagu Cy, Paris
3. Deftos L.J. Clinical Essentials of Calcium and Skeletal Disorders. 1998;102 Professional Communications, Caddo, OK
4. Econs M.J. New insights into the pathogenesis of inherited phosphate wasting disorders. Bone. 25:1999;131-135
5. Frost M. The origin and nature of transients in human bone remodeling dynamics. Frame B., Parfitt A.M., Duncan H. Clinical Aspects of Metabolic Bone Disease. 1973;124-140 Excerpta Medica, Amsterdam
6. Heller H.J., Pak C.Y.C. Primary hyperparathyroidism. Coe F.L., Favus M.J. Disorders of Bone and Mineral Metabolism. second edition:2002;516-534 Lippincott Williams and Wilkins, Philadelphia
7. Hruska K., Lederer E.D. Hyperphosphatemia and hypophosphatemia. Favus M.J. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th edition:2003;296-305 American Society for Bone and Mineral Research, Washington, DC
8. Lemann J. Urinary excretion of calcium, magnesium, and phosphorus. Favus M.J. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. second edition:1993;50-54 Raven Press, New York
9. Lentner C. Geigy Scientific Tables, Volume 1, Units of Measurements, Body Fluids, Composition of the Body, Nutrition. 1981;Ciba-Gieigy, Basle
10. Morris C. Academic Press Dictionary of Science and Technology. 1992;Academic Press, San Diego
11. Nagant de Deuxchaisnes C., Krane S.M. The treatment of adult phosphate diabetes and Fanconi syndrome with neutral sodium phosphate. Am. J. Med. 43:1967;508-543
12. Nelson A.E., Bligh R.C., Mirams M., Gill A., Au A., Clarkson A., et al. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J. Clin. Endocrinol. Metab. 88:2003;4088-4094
13. Parfitt A.M., Kleerekoper M. The divalent ion homeostatic system: physiology and metabolism of calcium, phosphorus, magnesium and bone. Maxwell M., Kleeman C.R. Clinical Disorders of Fluid and Electrolyte Metabolism. 3rd edition:1980;269-398 McGraw-Hill, New York
14. Parfitt A.M., Kleerekoper M. Clinical disorders of calcium, phosphorus, and magnesium metabolism. Maxwell M., Kleeman C.R. Clinical Disorders of Fluid and Electrolyte Metabolism. third edition:1980;947-1151 McGraw-Hill, New York
15. Quarles L.D. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am. J. Physiol.: Endocrinol. Metab. 285:2003;E1-E9
16. Traebert M., Roth J., Biber J., Murer H., Kaissling B. Internalization of proximal tubular type II Na-P (i) cotransporter by PTH: immunogold electron microscopy. Am. J. Physiol.: Renal, Fluid Electrolyte Physiol. 278:2000;F148-F154